Eagle Pharmaceuticals
EGRX
$1.54
Share price
15.00%
Change (1 day)
-77.50%
Change (1 year)
Categories
Earnings for Eagle Pharmaceuticals (EGRX)
Earnings in 2023 (TTM): S$47.63 Million
According to Eagle Pharmaceuticals 's latest financial reports the company's current earnings are S$0.25 Billion. In 2022 the company made an earning of S$88.13 Million, an increase over its 2021 earnings that were of -S$3.9 Million. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Eagle Pharmaceuticals from 2013 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | S$47.63 M | -45.95% |
| 2022 | S$88.13 M | -2361.45% |
| 2021 | -S$3.9 Million | -111.53% |
| 2020 | S$33.78 M | 2.31% |
| 2019 | S$33.02 M | -32.89% |
| 2018 | S$49.2 M | -50.35% |
| 2017 | S$99.11 M | 38.63% |
| 2016 | S$71.49 M | 1966.43% |
| 2015 | S$3.45 M | -111.46% |
| 2014 | -S$30.21 Million | 282.82% |
| 2013 | -S$7.89 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | S$23.33 B | 48,813.32% | 🇺🇸 USA |
 | S$5.87 B | 12,223.79% | 🇬🇧 UK |
 | S$18.24 B | 38,151.21% | 🇨🇭 Switzerland |
 | -S$0.38 Billion | -890.82% | 🇮🇱 Israel |
 | S$6.16 B | 12,825.21% | 🇺🇸 USA |
 | S$16.96 B | 35,460.17% | 🇺🇸 USA |
 | -S$11.22 Billion | -23,597.57% | 🇺🇸 USA |